PROX1 and cancer: Additionally, patients with high PROX1 expression had a worse prognosis according to cancer stage (pStage: I–II vs. III–IV), N status (pN: N0 vs. N1-3), lymphatic vascular invasion (negative vs. positive), and vascular invasion (negative vs. positive).